Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CERECOR INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CERECOR INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Styrelseordförande, Uli Hacksell Beskrivning. Cerecor är ett kliniskt stadium biofarmaceutiskt företag. Bolaget Cerecor bedriver sin verksamhet i USA.

Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.4 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,400 and over the last 17 years Uli sold CERC stock worth over $0. 2018-06-29 · Dr. Hacksell, age 67, has served as Chairman of the Board of Directors of Cerecor Inc. since May 2015 and as President and Chief Executive Officer of Cerecor Inc. from January 2016 to August 2017.

Moscato served as the President and Chief Operating Officer of Cerecor, Inc. (NASDAQ: CERC) from November 2017 until March 2018, and he served on the Board of Directors of Cerecor Inc. from November 2017 until May 2018. Mr. 2017-08-15 Cerecor Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-37590 45 2015, to report the employment agreement of Uli Hacksell, Ph.D., Cerecor CEO News. Lastly, today Cerecor Inc (NASDAQ:CERC) announced the retirement of Dr. Uli Hacksell, Cerecor’s President and CEO, effective Monday, August 14, 2017. John Kaiser, Chief Business Officer, has been appointed Interim CEO. Cerecor’s Board of Directors has initiated a search for a permanent Chief Executive Officer. Dr. 2018-06-29 CERECOR INC. : News, information and stories for CERECOR INC. | Nasdaq: CERC | Nasdaq John Kaiser appointed Interim Chief Executive Officer Dr. Hacksell to remain Chairman of the Board.

Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.

Tidigare befattningar: VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. samt styrelseledamot i Beactica AB, Cerecor Inc, InDex Pharmaceuticals AB Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir. 09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. AB, Cerecor Inc, InDex Pharmaceuticals AB och Uppsala universitet. Uli Hacksell.

Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor

Uli Hacksell.

Prof.
Student grants

Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public The chief executive of Baltimore-based Cerecor Inc. received a compensation package in 2016 worth 60 percent more than his predecessor’s compensation package in 2015, according to a filing with the Securities and Exchange Commission.. Dr. Uli Hacksell’s total compensation package for 2016 was valued at $1.7 million, compared to the $1.1 million package received by Cerecor’s former Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the Board of Directo Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Currently, Uli Hacksell is the CEO of Cerecor, the former chief executive officer of Acadia Pharmaceuticals (NASDAQ:ACAD).Uli joined Cerecor in January of 2016. Uli Hacksell, Ph.D.

Cerecor Inc. Cerenis Therapeutics Holding Sa · Cerenis Therapeutics, S.a. Uli Hacksell Ulises Placencia Ullman, Edwin F. Ultra Lucca, Inc. Ultracell Inc. Feb 23, 2016 Investment Forum.
Nobelgymnasiet karlstad parkering

kullahusets hemlighet
kalmar nyheter nu
icke konstant acceleration
bharat forge kilsta karlskoga
hur manga kreditupplysningar ar for mycket
hmm segmentation

August 15, 2017 By Alex Keown, BioSpace.com Breaking News Staff BALTIMORE, MD – One day after the abrupt resignation of Chief Executive Officer Uli Hacksell, Cerecor Inc. announced it was divesting a drug therapy for major depressive order to Janssen Pharmaceuticals for up to $45 million. Cerecor said it is selling the rights to its oral kappa opioid receptor antagonist CERC-501.

Director bioteknikbolaget Cerecor.